Glow Lifetech Announces Expansion into Manitoba Market and Portfolio Expansion in New Brunswick, Advancing National Growth Strategy 
VITUS Prostata Center Offenbach: How Electricity Can Effectively Kill Cancer
OFFENBACH, GERMANY / ACCESSWIRE / April 16, 2019 / Prostate cancer is the most common cancer in men, affecting 25%...
Virpax(R) Pharmaceuticals Licenses Molecular Envelope Technology (MET) Intranasal Formulation From Nanomerics Ltd.
Virpax® to Develop a Non-Opioid Molecular Envelope Technology (MET) Intranasal Formulation for the Management of Chronic Pain MALVERN, PA /...
Allysta Pharmaceuticals, Inc. Raises $15 Million in Series A Financing to Advance Novel Therapeutic for Dry Eye Disease
SAN MATEO, CA / ACCESSWIRE / April 16, 2019 / Allysta Pharmaceuticals, Inc. ("Allysta") today announced that they have completed...
Aytu BioScience Appoints Steven Boyd to the Company’s Board of Directors
ENGLEWOOD, CO / ACCESSWIRE / April 16, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
CEVEC Closes Major Financing Round To Further Expand And Commercialize Its Viral Vector Manufacturing Platform
Funding strengthens CEVEC's leading role in viral vector manufacturing technology CEVEC's technology allows for industrial scale manufacturing of AAV vectors...
AsclepiX Therapeutics Inc. Management to Present at the Solebury Trout Private Company Showcase
BALTIMORE, MD / ACCESSWIRE / April 15, 2019 / AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new...
Intellipharmaceutics Announces First Quarter 2019 Results
TORONTO, ON / ACCESSWIRE / April 15, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (''Intellipharmaceutics'' or the...
CTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory Board
Expansion brings expertise on Alzheimer's Disease and other neurodegenerative diseases to the SAB ALACHUA, FL / ACCESSWIRE / April 15,...
Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy
93% Primary Patency Rate and 100% Freedom from Target Lesion Revascularization at 12 Months REDWOOD CITY, CA / ACCESSWIRE /...
Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH)
ROCKVILLE, MD / ACCESSWIRE / April 15, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
NeuroOne Medical Technologies Corporation Appoints Chief Technology Officer
MINNETONKA, MN / ACCESSWIRE / April 15, 2019 / NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused...
Biom’up announces first US sales in laparoscopy for HEMOBLAST(TM) Bellows and the signing of an exclusive distribution agreement for HEMOBLAST(TM) Bellows in Australia
Successful launch of the HEMOBLAST Bellows Laparoscopic Applicator in the US, first sales booked in March 2019 Major framework agreement...
Easton Provides Update on the Closing of its Agreement To Acquire Commercial Bakery
TORONTO, ON / ACCESSWIRE / April 12, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) provides update on the closing...
MedStar Health and FDA to lead a post-conference workshop at Pre-Filled Syringes West Coast 2019
Developing a Human Factors Validation Plan with Consideration for the Digital Health MarketplaceThis workshop will provide an overview of human...
Angle PLC Announces Lung Cancer Study Uses Angle’s Parsortix System
Leading ANGLE Customer Has Established A Multi-Centre Study Using Parsortix Seeking to Identify Markers for Early Prediction of Cancer Relapse...
Evitrade Scientist Leads Discussions on Cannabis Education
VANCOUVER, BC / ACCESSWIRE / April 12, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF). Dr. Ricardo E...
CorMedix Notified of Compliance with NYSE American Listing Requirements
BERKELEY HEIGHTS, NJ / ACCESSWIRE / April 11, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Dr. Mike Golpa Launches Newest G4 By Golpa Dental Implant Surgery Center In Tysons Corner
Nationally-Acclaimed, State-Of-The-Art Dental Implant Solution to Make its DC Debut in June 2019 WASHINGTON, DC and LAS VEGAS, NV /...
Viveve Announces CE Mark Clearance for its Next Generation 2.0 Platform in the European Union
Viveve 2.0 system and its consumable treatment tips can now be sold in over 30 countries in addition to the...
Medidata Launches Acorn AI™ and Appoints Dr. Rama Kondru as CIO
Acorn AI is designed to answer the most important questions across R&D and commercialisation, enabling customers to improve outcomes for...